• GSK-923295 and CENP-E Inhibition: Precision Tools for Dissec

  2026-05-21

  Explore how GSK-923295, a potent CENP-E inhibitor, enables advanced investigation of chromosome alignment and cell cycle arrest in mitosis. Gain unique insights into centromere fidelity, informed by the latest mechanistic research and innovative assay strategies.

• Nuclear Export Inhibition Synergies in Triple-Negative Breas

  2026-05-21

  This study identifies combination therapies based on nuclear export inhibition for basal-like triple-negative breast cancer (TNBC). Using high-throughput screening, the authors discover that KPT-330 (Selinexor) in combination with a PI3K/mTOR inhibitor significantly reduces tumor burden in preclinical models, offering a targeted approach to overcome chemoresistance.

• Machine Learning Accelerates Senolytic Discovery in Cancer R

  2026-05-20

  The referenced study introduces a machine learning-driven approach to identify novel senolytic compounds, significantly reducing drug screening costs and expanding the landscape of potential therapeutics for cancer and age-related diseases. By leveraging published data, the team validated several potent senolytics, demonstrating artificial intelligence's capacity to advance targeted cell clearance strategies.

• Efficient iPSC-to-Retinal Ganglion Cell Differentiation via

  2026-05-20

  This study introduces a robust, chemically defined protocol for differentiating human iPSCs into retinal ganglion cells (RGCs) using dual SMAD and Wnt pathway inhibition. The approach achieves over 80% RGC purity and minimizes variability, enabling reproducible disease modeling and advancing research into glaucoma and neurodegenerative mechanisms.

• Methoxy-X04: Fluorescent Amyloid Beta Probe for Advanced AD

  2026-05-19

  Methoxy-X04 is a brain-permeable fluorescent amyloid beta probe that enables rapid, high-affinity detection of amyloid plaques and oligomers in live models. Its compatibility with in vivo imaging and cutting-edge techniques like rTMS makes it a gold standard for Alzheimer’s disease research and translational workflow optimization.

• PA-824: Bicyclic Nitroimidazole for Tuberculosis Research

  2026-05-19

  PA-824 stands out as a high-purity bicyclic nitroimidazole derivative, providing reproducible and highly sensitive workflows for both drug-sensitive and drug-resistant Mycobacterium tuberculosis research. This article translates cutting-edge mechanistic insights and validated protocols into actionable steps for tuberculosis labs, with troubleshooting tips based on real-world scenarios.

• Neuroinflammation and Piezo2 Signaling in Trigeminal Allodyn

  2026-05-18

  Liao et al. reveal a neuroinflammatory cascade linking trigeminal nerve root compression to mechanical allodynia via a Ca2+-dependent CGRP/SP-Piezo2 axis in rats. Their work clarifies the interplay between ATP-driven signaling, neuropeptide upregulation, and mechanotransduction, establishing a foundation for targeted intervention in trigeminal neuralgia.

• (-)-Epigallocatechin Gallate: Advanced Workflows in Apoptosi

  2026-05-18

  (-)-Epigallocatechin gallate (EGCG) unlocks precise control over apoptosis and inflammation in regenerative medicine, with new delivery strategies boosting efficacy in intervertebral disc degeneration (IVDD) models. Recent innovations in dual-network hydrogels and mechanistic targeting are reshaping how researchers deploy this green tea catechin antioxidant for translational success.

• (-)-Epinephrine (+)-bitartrate: Precision Control in Adrener

  2026-05-17

  Explore the pivotal role of Epinephrine Bitartrate as a non-selective adrenergic receptor agonist in cutting-edge research. This article unpacks assay optimization, translational insights, and evidence-driven dosing—revealing applications and limitations missed by prior content.

• Decoding Cell Death Pathways with Luminescent ATP Cell Viabi

  2026-05-16

  Explore how the Luminescent ATP Cell Viability Assay Kit I empowers precise cell viability measurement and mechanistic dissection of regulated cell death. This article uniquely bridges the latest ferroptosis research with advanced luciferase luminescence detection.

• TMEM16F Lipid Scrambling Modulates Ferroptosis and Tumor Imm

  2026-05-15

  Yang et al. identify TMEM16F-mediated lipid scrambling as a key suppressor of ferroptosis, orchestrating plasma membrane integrity and influencing tumor immune rejection. This mechanistic insight advances the understanding of ferroptotic cell death execution and presents new therapeutic angles for cancer immunotherapy.

• hly Gene Deletion Impairs Biofilm and Antibiotic Response in

  2026-05-15

  This study demonstrates that deletion of the hly gene in Listeria monocytogenes severely compromises biofilm formation and increases susceptibility to ribosome-targeting antibiotics. The findings highlight hly's role in coordinating biofilm architecture, motility, and virulence, suggesting new intervention points for controlling persistent foodborne contamination.

• Extracellular Disulfide Bonds Govern OATP1B1 Surface Express

  2026-05-14

  This study defines the essential roles of extracellular disulfide bonds in the surface expression and transport function of human OATP1B1. By combining mutagenesis and specific biotinylation assays, the authors show that all extracellular cysteines are engaged in disulfide bonding, with particular pairs being crucial for protein trafficking and activity—insights that inform both basic transporter biology and applied protein biochemistry.

• GKT137831 (SKU B4763): Data-Driven Solutions for Redox Assay

  2026-05-14

  This article delivers scenario-based guidance for deploying GKT137831 (SKU B4763), a dual NADPH oxidase Nox1/Nox4 inhibitor, within advanced cell viability and oxidative stress workflows. By addressing common laboratory challenges and integrating quantitative evidence, it empowers researchers to enhance reproducibility, data clarity, and assay performance in oxidative stress and vascular remodeling studies.

• GM 6001 (Galardin): Workflow and Troubleshooting in MMP Inhi

  2026-05-13

  GM 6001 (Galardin) sets the benchmark for precise, reproducible inhibition of MMP-1, MMP-2, MMP-3, MMP-8, and MMP-9, empowering advanced extracellular matrix and signaling studies. This guide translates cutting-edge research and real-world troubleshooting into actionable protocols for cancer, meniscal healing, and vascular biology applications.

16338 records 1/1090 page Next 12345 下5页 Last page